Click on headlines below to download research

Treakisym approvals should lead to sales uplift
SymBio Pharmaceuticals | 06/01/2017

SymBio recently obtained approvals for Treakisym in Japan in the additional indications of first-line low grade non-Hodgkin’s lymphoma (NHL) and…

With experience comes confidence
SymBio Pharmaceuticals | 23/03/2016

Three steps forward, one step back. With the December filing of three supplemental NDAs for Treakisym, SymBio is demonstrating it is willing to move ahead…

With experience comes confidence
SymBio Pharmaceuticals | 21/03/2016

Three steps forward, one step back. With the December filing of three supplemental NDAs for Treakisym, SymBio is demonstrating it is willing to move ahead…